Cargando…

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry

Viruses are a major threat to human health and economic well-being. In recent years Ebola, Zika, influenza, and chikungunya virus epidemics have raised awareness that infections can spread rapidly before vaccines or specific antagonists can be made available. Broad-spectrum antivirals are drugs with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazzon, Michela, Ortega-Prieto, Ana Maria, Imrie, Douglas, Luft, Christin, Hess, Lena, Czieso, Stephanie, Grove, Joe, Skelton, Jessica Katy, Farleigh, Laura, Bugert, Joachim J., Wright, Edward, Temperton, Nigel, Angell, Richard, Oxenford, Sally, Jacobs, Michael, Ketteler, Robin, Dorner, Marcus, Marsh, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410080/ https://www.ncbi.nlm.nih.gov/pubmed/30791609 http://dx.doi.org/10.3390/v11020176

Ejemplares similares

Targeting viral entry as a strategy for broad-spectrum antivirals
por: Mazzon, Michela, et al.
Publicado: (2019)

Development and validation of RdRp Screen, a crystallization screen for viral RNA-dependent RNA polymerases
por: Riccio, Federica, et al.
Publicado: (2019)

Electroporation Knows No Boundaries: The Use of Electrostimulation for siRNA Delivery in Cells and Tissues
por: Luft, Christin, et al.
Publicado: (2015)

Evasion of a Human Cytomegalovirus Entry Inhibitor with Potent Cysteine Reactivity Is Concomitant with the Utilization of a Heparan Sulfate Proteoglycan-Independent Route of Entry
por: Murray, M. J., et al.
Publicado: (2020)

A CRISPR CASe for high-throughput silencing
por: Heintze, Jacob, et al.
Publicado: (2013)

Lipid interactions during virus entry and infection
por: Mazzon, Michela, et al.
Publicado: (2014)

A Hitchhiker's guide to humanized mice: new pathways to studying viral infections
por: Skelton, Jessica Katy, et al.
Publicado: (2018)

The cell biology of receptor-mediated virus entry
por: Grove, Joe, et al.
Publicado: (2011)

Phosphodiesterase-induced cAMP degradation restricts hepatitis B virus infection
por: Evripioti, Antonia Alexandra, et al.
Publicado: (2019)

Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses
por: Lu, Shengsheng, et al.
Publicado: (2021)

HTCC: Broad Range Inhibitor of Coronavirus Entry
por: Milewska, Aleksandra, et al.
Publicado: (2016)

Seroprevalence of Molluscum contagiosum Virus in German and UK Populations
por: Sherwani, Subuhi, et al.
Publicado: (2014)

Broad Host Tropism of Flaviviruses during the Entry Stage
por: Zhang, Yanan, et al.
Publicado: (2023)

Automated high-content imaging in iPSC-derived neuronal progenitors
por: Papandreou, Apostolos, et al.
Publicado: (2023)

Mining of Ebola virus entry inhibitors identifies approved drugs as two-pore channel pore blockers()
por: Penny, Christopher J., et al.
Publicado: (2019)

Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry
por: Long, Jason, et al.
Publicado: (2015)

Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry
por: Lin, Liang-Tzung, et al.
Publicado: (2013)

Anti‐flavivirus Activity of Different Tritylated Pyrimidine and Purine Nucleoside Analogues
por: McGuigan, Christopher, et al.
Publicado: (2016)

Benzobisthiazoles Represent a Novel Scaffold for Kinase Inhibitors of CLK Family Members
por: Prak, Krisna, et al.
Publicado: (2015)

Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2
por: Groß, Rüdiger, et al.
Publicado: (2022)

Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice
por: Skelton, Jessica Katy, et al.
Publicado: (2019)

Virus Entry: Open Sesame
por: Marsh, Mark, et al.
Publicado: (2006)

Virus Entry into Animal Cells
por: Marsh, Mark, et al.
Publicado: (1989)

Binding and entry of animal viruses
por: Sommerfelt, Maja A., et al.
Publicado: (1989)

Application of Gaussia luciferase in bicistronic and non-conventional secretion reporter constructs
por: Luft, Christin, et al.
Publicado: (2014)

A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry
por: Herschhorn, Alon, et al.
Publicado: (2014)

Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry
por: Caì, Yíngyún, et al.
Publicado: (2019)

A Membrane Topology Model for Human Interferon Inducible Transmembrane Protein 1
por: Weston, Stuart, et al.
Publicado: (2014)

Structured data entry for narrative data in a broad specialty: patient history and physical examination in pediatrics
por: Bleeker, Sacha E, et al.
Publicado: (2006)

Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies
por: Chikere, Kelechi, et al.
Publicado: (2014)

Building a mechanistic mathematical model of hepatitis C virus entry
por: Kalemera, Mphatso, et al.
Publicado: (2019)

IFITM proteins — cellular inhibitors of viral entry
por: Smith, SE, et al.
Publicado: (2014)

Mechanisms of enveloped virus entry into animal cells
por: Klasse, Per Johan, et al.
Publicado: (1998)

The Nef Protein of the Macrophage Tropic HIV-1 Strain AD8 Counteracts Human BST-2/Tetherin
por: Giese, Sebastian, et al.
Publicado: (2020)

KHNYN is essential for the zinc finger antiviral protein (ZAP) to restrict HIV-1 containing clustered CpG dinucleotides
por: Ficarelli, Mattia, et al.
Publicado: (2019)

Bat and pig IFN-induced transmembrane protein 3 restrict cell entry by influenza virus and lyssaviruses
por: Benfield, Camilla T. O., et al.
Publicado: (2015)

Broad-Spectrum Antiviral Therapeutics
por: Rider, Todd H., et al.
Publicado: (2011)

Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015)

Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches
por: Tsefou, Eliona, et al.
Publicado: (2021)

PRO 2000, a broadly active anti-HIV sulfonated compound, inhibits viral entry by multiple mechanisms
por: Huskens, Dana, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_nc64krrofbkah5c6ifupftcdda